Fosun Internatio Stock Price, News & Analysis

Fosun has initiated a global campaign for a malaria-free world, aligning with World Malaria Day on April 25. The campaign involved various charitable activities in over 15 countries from April 20 to April 26, emphasizing investment and innovation.

Fosun Pharma, leveraging over 30 years of expertise, has distributed over 280 million artesunate injections, saving over 56 million lives, primarily in Africa. The company launched a production facility in Ivory Coast in November 2022 to enhance local pharmaceutical access, which is expected to produce one billion tablets by 2024.

A charity song performed at a Premier League match further promoted the campaign, and Fosun's landmarks globally illuminated messages supporting malaria eradication. The company also aims to establish long-term charitable mechanisms in Africa, collaborating with various organizations to combat malaria effectively.

Fosun International reported a revenue of RMB 175.39 billion for 2022, an 8.7% increase despite challenges from the pandemic and international market volatility, with a net profit of RMB 0.54 billion. The company emphasized recovery in 2023, particularly in tourism and commercial sectors, and expressed confidence in future growth. Fosun divested non-core assets to streamline operations and focused on core business strengths. Notably, it received an MSCI ESG rating of AA and maintained stable debt ratios. The company aims to enhance product competitiveness through innovation and global operations while continuing to prioritize ESG responsibilities.

Fosun International announced its 2022 annual results, highlighting a total revenue of RMB175.39 billion, up 8.7% year-on-year. Overseas revenue reached RMB77.4 billion, representing a 14% increase and making up 44% of total revenue. The company invested RMB10.4 billion in R&D, marking a 17% rise. However, net profit was RMB0.54 billion, a sharp decline from RMB10.08 billion in 2021 due to high business costs and market downturns. Fosun has focused on divesting non-core assets, generating cash inflows of nearly RMB30 billion to stabilize operations. As of January 2023, they secured a RMB12 billion syndicated loan.

On March 17-18, Guo Guangchang, Chairman of Fosun, participated in major economic forums in China, emphasizing innovation and global operations. In an interview, Guo highlighted Fosun's R&D investments, particularly in biopharmaceuticals, and expressed confidence in achieving set development goals for the year. The tourism sector shows significant recovery, with Atlantis Sanya's occupancy exceeding 90%. Fosun's diverse businesses demonstrated strong performance, with Yuyuan Garden attracting over 4 million visitors and Club Med achieving record business volumes. Guo called for maintaining corporate health and innovation as essential for sustainable growth.

The Yuyuan Garden Lantern Festival in Shanghai recently hosted consular officials from 51 countries, showcasing Chinese culture through vibrant lantern displays and traditional performances. Co-hosted by the Foreign Affairs Office of Shanghai, this year's festival featured themes from the classic 'The Classic of Mountains and Seas' and integrated digital technologies for an enhanced experience. Approximately 3 million visitors have attended, including a significant number from the younger generation. The event received international attention, with promotion from the Chinese Ministry of Foreign Affairs and participation in various events abroad, solidifying its status as a cultural highlight.

On February 4, 2023, at Molineux Stadium, Wolverhampton Wanderers celebrated the Lantern Festival with a vibrant event featuring traditional Rabbit Lanterns from the Yuyuan Garden Lantern Festival. The Wolves, who defeated Liverpool 3-0 in the Premier League, showcased cultural exchanges through festive displays and messages. Fosun, the owner of Wolves, aims to promote Chinese culture globally. The event attracted over 30,000 fans and marked the first introduction of the Chinese Lantern Festival to the Premier League, highlighting China's cultural heritage and enhancing Fosun's brand visibility.

On January 9, 2023, Fosun Foundation partnered with Fosun Pharma and Genuine Biotech to donate RMB100 million worth of Azvudine tablets aimed at combating COVID-19 in rural areas during the peak season following Chinese New Year. By January 29, 173,200 bottles were distributed across 116 counties in 19 regions, benefiting approximately 150,000 villagers, notably seniors over 65. The initiative faced challenges in logistics and timely distribution, but volunteer efforts facilitated the delivery process. Additionally, Fosun Foundation is enhancing the skills of rural doctors through specialized training and providing essential medical supplies and digital healthcare systems.